Skip to content

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04714840
Enrollment
181
Registered
2021-01-19
Start date
2021-02-08
Completion date
2026-02-23
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer, Mobility Limitation

Brief summary

The participants are asked to take part in this clinical trial, a type of research study. The participants are SJLIFE study participants and may have a hard time exercising (exercise intolerance) due to side effects of cancer treatment received as a child.This study is being done to determine if a personalized exercise plan will help childhood cancer survivors who have exercise intolerance become more active. Primary Objectives: To achieve the goal of this study, we propose the following three Objectives: Primary Objective 1: To determine the efficacy of an individually tailored, home-delivered aerobic and strengthening intervention to improve exercise capacity in survivors of childhood cancer with exercise intolerance (peak oxygen uptake (peak VO2) \<85% of age and sex predicted). Primary Objective 2: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on measures of cardiac, pulmonary, musculoskeletal, and neurosensory function in survivors of childhood cancer with exercise intolerance. Primary Objective 3: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on emotional health, participation in family and community activities, quality of life, and cognitive function in survivors of childhood cancer with exercise intolerance.

Detailed description

The design for this study will be a single-blind two-arm, prospective, randomized clinical trial. Performance testing results: Both groups of participants will be provided with the results of their performance testing. Individually tailored exercise program: Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist.Generalized exercise recommendations: Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans.

Interventions

OTHERExercise testing results

Tailored, home-delivered aerobic and strengthening intervention,exercise intolerance,Both groups of participants will be provided with the results of their exercise testing.

OTHERIndividually tailored exercise program (INT)

Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist. Written instructions, videos of each strengthening exercise, a blue tooth enable heart rate monitor, all necessary exercise equipment, and an iPad pre-loaded with heart rate monitor software, exercise videos and ZOOM app (for video conferencing) will be provided. After returning home, the exercise specialist will supervise and provide guidance to the individual via the ZOOM app during the first 2 weeks (3 sessions per week). Supervision will slowly decrease to twice a week in weeks 3-4, once a week in weeks 5-8, every other week in weeks 9-16, and to one time midway between weeks 17-20. The exercise program will be adjusted depending on the individuals progress.

OTHERGeneralized exercise recommendations (AC)

Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans. At the baseline visit, a study staff will review these guidelines and answer questions about their exercise testing and encourage them to be physically active. The staff will contact them via telephone to complete a short questionnaire weekly during weeks 1-8 and monthly for weeks 9-20.

Sponsors

St. Jude Children's Research Hospital
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Between 18.00 and 39.99 years of age at the time of enrollment * SJLIFE participant * Peak VO2 \<85% predicted * Verbalizes understanding of directions for use of ZOOM on the study provided iPad and heart rate monitor * Clearance for participation in exercise by a study physician * Internet access

Exclusion criteria

* Enrolled in a formal exercise intervention * Self-report of engaging in \> 150 minutes/week of moderate physical activity * Currently pregnant (assess by urine pregnancy test) * Significant psychological distress (e.g. suicidal ideation) * Requires immediate medical intervention (e.g. angina, decompensated heart failure) * Research Participant Recruitment and Screening

Design outcomes

Primary

MeasureTime frameDescription
Exercise CapacityBaseline to Week 20Changes in Peak VO2/2-minute step in place test in both INT and AC groups
Exercise capacityWeek 20 to 6 months after week 20Sustainability of changes in Peak VO2/2-minute step in place test in both INT and AC groups

Secondary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9)baseline, week 20, 6 months after week 20Scale: 4 Options - Not at all (minimum value = 0), Several days (1), More than half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-27.
Generalized Anxiety Disorder (GAD-7)baseline, week 20, 6 months after week 20Scale: 5 Options - Not at all sure (minimum value = 0), Several days (1), Over half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-21.
PROMIS Ability to Participate 8a (SF v2.0)baseline, week 20, 6 months after week 20Scale: 5 Options - Never (maximum value = 5), Rarely (4), Sometimes (3), Usually (2), Always (minimum value = 1). Higher score = better outcome. Possible score range 8-40.
Work Productivity and Activity Impairment Questionnaire (WPAI)baseline, week 20, 6 months after week 20Scale doesn't apply to overall questionnaire. Outcomes are expressed as impairment percentages. Higher numbers = worse outcome.
Work and Social Adjustment Scale (WSAS)baseline, week 20, 6 months after week 20Scale: 0-8; Not at all (minimum value = 0) to Very Severely (maximum value = 8). Higher score = worse outcome. Possible score range 0-40.
Medical Outcomes Survey Short Form (SF-36)baseline, week 20, 6 months after week 20Consists of 8 scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Higher score = better outcome.
Childhood Cancer Survivor Study Neurocognitive Questionnaire - Revised (CCSS-NCQ)baseline, week 20, 6 months after week 20Scale: 3 Options - Never a Problem (maximum value = 2), Sometimes a Problem (1) , Often a Problem (minimum value = 0). Higher score = better outcome. Possible score range 0-64.
PROMIS Global Health Short Formsweekly during the first eight weeks and every four weeks during weeks 9-20brief global physical and mental health questionnaires; Scale: 5-point Likert scale, Excellent=5, Poor=1

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKirsten Ness, PhD

St. Jude Children's Research Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026